Methamphetamine

Illicit stimulants, specifically cocaine and methamphetamine, remain a pervasive drug threat in Pennsylvania. PFD offices, state/local law enforcement agencies, and other stakeholders throughout Pennsylvania report persistent increases since 2017 in various indicators that demonstrate availability, such as the total quantity of illicit stimulants seized by law enforcement, identification of seized drugs as illicit stimulants by laboratory analysis, and the presence of illicit stimulants in drug-related overdose deaths.

The Drug Enforcement Administration’s (DEA) Philadelphia Field Division (PFD) Intelligence Program conducted an analysis of drug availability and abuse for the State of Delaware. This product highlights significant findings regarding various drug trends since last reported in 2017.

The primary drug threats identified in Delaware are illicit opioids, cocaine, controlled prescription drugs, and methamphetamine. The determination of drug threats in Delaware considers a variety of factors including: availability, threat to public health, community impact, attendant crime, enforcement activity, seizures, drug abuse and treatment statistics, and propensity for abuse.

The PFD Intelligence Program analyzed the following indicators in this assessment: illicit and controlled prescription drug availability; drug prices and purity; and fatal drug-related overdose data.

DEA's revised and updated drug fact sheet about the class of drugs known as methamphetamines - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the minds and bodies of users including signs of overdose, and its legal status. 

DEA Acting Administrator Uttam Dhillon announces Operation Crystal Shield in response to a dramatic increase in methamphetamine trafficking through eight major cities in the U.S.  The press conference took place at the DEA Field Division Headquarters in Atlanta, Georgia on February 20, 2020.